Recent Patents on Anti-Cancer Drug Discovery This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

UBE2L3 Promotes Oxidative Stress-regulated Necroptosis to Accelerate Osteosarcoma Progression
CONCLUSION: UBE2L3 is upregulated in osteosarcoma cells, and silencing of UBE2L3 promotes oxidative stress in these cells, leading to enhanced necroptosis and delayed progression of osteosarcoma.PMID:38385491 | DOI:10.2174/0115748928297557240212112531 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - February 22, 2024 Category: Cancer & Oncology Authors: Xiwu Zhao Guoqiang Shan Deguo Xing Hongwei Gao Zhenggang Xiong Wenpeng Hui Mingzhi Gong Source Type: research

Survival Benefits of Ganoderma Lucidum in Early-stage Triple-negative Breast Cancer: A Real World Study
CONCLUSIONS: The results of this real-world propensity-score-matched study suggest that GLSP can improve OS and DFS in early-stage TNBC patients. A higher OS was observed for patients taking GLSP, particularly in stage II and stage III.PMID:38385492 | DOI:10.2174/0115748928282946240111114448 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - February 22, 2024 Category: Cancer & Oncology Authors: Baohong Jiang Na Li Wei Du Lijun Zeng Yuanbin Tang Lunqi Luo Hongbo Zhu Feng Ye Source Type: research

UBE2L3 Promotes Oxidative Stress-regulated Necroptosis to Accelerate Osteosarcoma Progression
CONCLUSION: UBE2L3 is upregulated in osteosarcoma cells, and silencing of UBE2L3 promotes oxidative stress in these cells, leading to enhanced necroptosis and delayed progression of osteosarcoma.PMID:38385491 | DOI:10.2174/0115748928297557240212112531 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - February 22, 2024 Category: Cancer & Oncology Authors: Xiwu Zhao Guoqiang Shan Deguo Xing Hongwei Gao Zhenggang Xiong Wenpeng Hui Mingzhi Gong Source Type: research

Survival Benefits of Ganoderma Lucidum in Early-stage Triple-negative Breast Cancer: A Real World Study
CONCLUSIONS: The results of this real-world propensity-score-matched study suggest that GLSP can improve OS and DFS in early-stage TNBC patients. A higher OS was observed for patients taking GLSP, particularly in stage II and stage III.PMID:38385492 | DOI:10.2174/0115748928282946240111114448 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - February 22, 2024 Category: Cancer & Oncology Authors: Baohong Jiang Na Li Wei Du Lijun Zeng Yuanbin Tang Lunqi Luo Hongbo Zhu Feng Ye Source Type: research

UBE2L3 Promotes Oxidative Stress-regulated Necroptosis to Accelerate Osteosarcoma Progression
CONCLUSION: UBE2L3 is upregulated in osteosarcoma cells, and silencing of UBE2L3 promotes oxidative stress in these cells, leading to enhanced necroptosis and delayed progression of osteosarcoma.PMID:38385491 | DOI:10.2174/0115748928297557240212112531 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - February 22, 2024 Category: Cancer & Oncology Authors: Xiwu Zhao Guoqiang Shan Deguo Xing Hongwei Gao Zhenggang Xiong Wenpeng Hui Mingzhi Gong Source Type: research

Survival Benefits of Ganoderma Lucidum in Early-stage Triple-negative Breast Cancer: A Real World Study
CONCLUSIONS: The results of this real-world propensity-score-matched study suggest that GLSP can improve OS and DFS in early-stage TNBC patients. A higher OS was observed for patients taking GLSP, particularly in stage II and stage III.PMID:38385492 | DOI:10.2174/0115748928282946240111114448 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - February 22, 2024 Category: Cancer & Oncology Authors: Baohong Jiang Na Li Wei Du Lijun Zeng Yuanbin Tang Lunqi Luo Hongbo Zhu Feng Ye Source Type: research

UBE2L3 Promotes Oxidative Stress-regulated Necroptosis to Accelerate Osteosarcoma Progression
CONCLUSION: UBE2L3 is upregulated in osteosarcoma cells, and silencing of UBE2L3 promotes oxidative stress in these cells, leading to enhanced necroptosis and delayed progression of osteosarcoma.PMID:38385491 | DOI:10.2174/0115748928297557240212112531 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - February 22, 2024 Category: Cancer & Oncology Authors: Xiwu Zhao Guoqiang Shan Deguo Xing Hongwei Gao Zhenggang Xiong Wenpeng Hui Mingzhi Gong Source Type: research

Survival Benefits of Ganoderma Lucidum in Early-stage Triple-negative Breast Cancer: A Real World Study
CONCLUSIONS: The results of this real-world propensity-score-matched study suggest that GLSP can improve OS and DFS in early-stage TNBC patients. A higher OS was observed for patients taking GLSP, particularly in stage II and stage III.PMID:38385492 | DOI:10.2174/0115748928282946240111114448 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - February 22, 2024 Category: Cancer & Oncology Authors: Baohong Jiang Na Li Wei Du Lijun Zeng Yuanbin Tang Lunqi Luo Hongbo Zhu Feng Ye Source Type: research

UBE2L3 Promotes Oxidative Stress-regulated Necroptosis to Accelerate Osteosarcoma Progression
CONCLUSION: UBE2L3 is upregulated in osteosarcoma cells, and silencing of UBE2L3 promotes oxidative stress in these cells, leading to enhanced necroptosis and delayed progression of osteosarcoma.PMID:38385491 | DOI:10.2174/0115748928297557240212112531 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - February 22, 2024 Category: Cancer & Oncology Authors: Xiwu Zhao Guoqiang Shan Deguo Xing Hongwei Gao Zhenggang Xiong Wenpeng Hui Mingzhi Gong Source Type: research

Survival Benefits of Ganoderma Lucidum in Early-stage Triple-negative Breast Cancer: A Real World Study
CONCLUSIONS: The results of this real-world propensity-score-matched study suggest that GLSP can improve OS and DFS in early-stage TNBC patients. A higher OS was observed for patients taking GLSP, particularly in stage II and stage III.PMID:38385492 | DOI:10.2174/0115748928282946240111114448 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - February 22, 2024 Category: Cancer & Oncology Authors: Baohong Jiang Na Li Wei Du Lijun Zeng Yuanbin Tang Lunqi Luo Hongbo Zhu Feng Ye Source Type: research

UBE2L3 Promotes Oxidative Stress-regulated Necroptosis to Accelerate Osteosarcoma Progression
CONCLUSION: UBE2L3 is upregulated in osteosarcoma cells, and silencing of UBE2L3 promotes oxidative stress in these cells, leading to enhanced necroptosis and delayed progression of osteosarcoma.PMID:38385491 | DOI:10.2174/0115748928297557240212112531 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - February 22, 2024 Category: Cancer & Oncology Authors: Xiwu Zhao Guoqiang Shan Deguo Xing Hongwei Gao Zhenggang Xiong Wenpeng Hui Mingzhi Gong Source Type: research

Survival Benefits of Ganoderma Lucidum in Early-stage Triple-negative Breast Cancer: A Real World Study
CONCLUSIONS: The results of this real-world propensity-score-matched study suggest that GLSP can improve OS and DFS in early-stage TNBC patients. A higher OS was observed for patients taking GLSP, particularly in stage II and stage III.PMID:38385492 | DOI:10.2174/0115748928282946240111114448 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - February 22, 2024 Category: Cancer & Oncology Authors: Baohong Jiang Na Li Wei Du Lijun Zeng Yuanbin Tang Lunqi Luo Hongbo Zhu Feng Ye Source Type: research

UBE2L3 Promotes Oxidative Stress-regulated Necroptosis to Accelerate Osteosarcoma Progression
CONCLUSION: UBE2L3 is upregulated in osteosarcoma cells, and silencing of UBE2L3 promotes oxidative stress in these cells, leading to enhanced necroptosis and delayed progression of osteosarcoma.PMID:38385491 | DOI:10.2174/0115748928297557240212112531 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - February 22, 2024 Category: Cancer & Oncology Authors: Xiwu Zhao Guoqiang Shan Deguo Xing Hongwei Gao Zhenggang Xiong Wenpeng Hui Mingzhi Gong Source Type: research

Survival Benefits of Ganoderma Lucidum in Early-stage Triple-negative Breast Cancer: A Real World Study
CONCLUSIONS: The results of this real-world propensity-score-matched study suggest that GLSP can improve OS and DFS in early-stage TNBC patients. A higher OS was observed for patients taking GLSP, particularly in stage II and stage III.PMID:38385492 | DOI:10.2174/0115748928282946240111114448 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - February 22, 2024 Category: Cancer & Oncology Authors: Baohong Jiang Na Li Wei Du Lijun Zeng Yuanbin Tang Lunqi Luo Hongbo Zhu Feng Ye Source Type: research

UBE2L3 Promotes Oxidative Stress-regulated Necroptosis to Accelerate Osteosarcoma Progression
CONCLUSION: UBE2L3 is upregulated in osteosarcoma cells, and silencing of UBE2L3 promotes oxidative stress in these cells, leading to enhanced necroptosis and delayed progression of osteosarcoma.PMID:38385491 | DOI:10.2174/0115748928297557240212112531 (Source: Recent Patents on Anti-Cancer Drug Discovery)
Source: Recent Patents on Anti-Cancer Drug Discovery - February 22, 2024 Category: Cancer & Oncology Authors: Xiwu Zhao Guoqiang Shan Deguo Xing Hongwei Gao Zhenggang Xiong Wenpeng Hui Mingzhi Gong Source Type: research